TP53 and angiosarcoma: Other investigations have also reported frequent TP53 mutations in human angiosarcomas.[7–9] Collectively, these genetic studies strongly suggest that the PI3K, MAPK, and TP53 pathways play an important role in the development of angiosarcoma.